Oncolytic Herpes Virus
Showing 1 - 25 of 7,885
Sarcoma, Carcinoma, Digestive Cancer Trial in Linyi (Recombinant oncolytic herpes simplex virus type 1 (R130))
Recruiting
- Sarcoma
- +9 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Linyi, Shandong, ChinaLinyi Central Hospital
Jul 25, 2023
Sarcoma, Carcinoma, Breast Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type 1 (R130))
Recruiting
- Sarcoma
- +8 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Shanghai, Jiangsu, ChinaXuzhou Second People's Hospital
May 8, 2023
Cervical Cancer, Endometrial Cancer, Advanced Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type ?
Recruiting
- Cervical Cancer
- +2 more
- Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
-
Shanghai, Shanghai, ChinaShanghai Tenth People's Hospital
Mar 31, 2023
Osteosarcoma, Sarcoma, Sarcoma,Soft Tissue Trial in Xi'an (Recombinant oncolytic herpes simplex virus type ? (R130))
Recruiting
- Osteosarcoma
- +3 more
- Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
-
Xi'an, Shaanxi, ChinaXi'an Honghui Hospital
May 8, 2023
Ovarian Cancer, Peritoneal Carcinomatosis, Fallopian Tube Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus
Recruiting
- Ovarian Cancer
- +2 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Shanghai, Shanghai, ChinaShanghai Tenth People's Hospital
Mar 26, 2023
Head Neck Cancer, Esophageal Cancer, Otorhinolaryngologic Tumors Trial in Shanghai (Recombinant oncolytic herpes simplex virus
Recruiting
- Head and Neck Cancer
- +6 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Shanghai, ChinaEye & ENT Hospital of Fudan University
Apr 13, 2023
Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1
Recruiting
- Lung Cancer
- +11 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Anqing, Anhui, ChinaThe PLA Navy Anqing Hospital
May 23, 2023
Uterine Cervical Tumors Trial in Wuhan (BS-006)
Not yet recruiting
- Uterine Cervical Neoplasms
- BS-006
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Jun 6, 2022
Pancreatic Cancer Trial in Chongqing (OH2 injection)
Recruiting
- Pancreatic Cancer
- OH2 injection
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Jan 27, 2022
Malignant Tumor Trial in Chengdu (Oncolytic Virus SDJ001, Oncolytic Virus YD06-1)
Recruiting
- Malignant Tumor
- Oncolytic Virus SDJ001
- Oncolytic Virus YD06-1
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Oct 6, 2023
Metastatic NSCLC, Metastatic Triple-negative Breast Cancer Trial in Houston (biological, drug, radiation)
Active, not recruiting
- Metastatic Non-small Cell Lung Cancer
- Metastatic Triple-negative Breast Cancer
- ADV/HSV-tk
- +3 more
-
Houston, TexasHouston Methodist Cancer Center
Dec 28, 2022
Advanced Bladder Carcinoma Trial in Wuhan (OH2 injection)
Recruiting
- Advanced Bladder Carcinoma
- OH2 injection
-
Wuhan, Hubei, ChinaTongji Hospital, Tongji Medical College of Huazhong University o
Aug 5, 2022
Advanced Solid Tumors Trial in Hangzhou, Shanghai (Recombinant human IL-21 oncolytic vaccinia virus injection)
Not yet recruiting
- Advanced Solid Tumors
- Recombinant human IL-21 oncolytic vaccinia virus injection
-
Hangzhou, Zhejiang, China
- +1 more
Jun 21, 2023
CNS Tumors Trial in Beijing (OH2 injection)
Recruiting
- Central Nervous System Tumors
- OH2 injection
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital, Capital Medical University
Feb 2, 2023
Melanoma Trial in Beijing (OH2 injection, HX008 injection)
Recruiting
- Melanoma
- OH2 injection
- HX008 injection
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Jan 28, 2023
Virus, HSV-1, Herpes Simplex 1 Trial in Pocatello, Saint George (Purell Hand Sanitizer, Medical Grade Mineral Oil)
Recruiting
- Virus
- +3 more
- Purell Hand Sanitizer
- Medical Grade Mineral Oil
-
Pocatello, Idaho
- +2 more
Nov 13, 2023
Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event Trial in Beijing (Ad-TD-nsIL12)
Recruiting
- Oncolytic Virus
- +2 more
- Ad-TD-nsIL12
-
Beijing, Beijing, ChinaSanbo Brain Hospital, Capital Medical University
Jan 29, 2023
Non-muscle-invasive Bladder Cancer Trial in Beijing (OH2 injection)
Recruiting
- Non-muscle-invasive Bladder Cancer
- OH2 injection
-
Beijing, Beijing, ChinaNational Cancer Center/Cancer Hospital, Chinese Academy of Medic
Jul 12, 2022
Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event Trial in Beijing (Ad-TD-nsIL12)
Recruiting
- Oncolytic Virus
- +2 more
- Ad-TD-nsIL12
-
Beijing, Beijing, ChinaSanbo Brain Hospital, Capital Medical University
Jan 29, 2023
Frequency of Symptomatic Herpes Virus I and II in HIV Infected
Recruiting
- HIV Disease
- +2 more
- Blood draw
-
Los Angeles, CaliforniaGlobal Research Institute
Apr 9, 2023
Protein Biomarkers in Neonatal Herpes Simplex Virus Infection
Completed
- Neonatal Herpes Simplex Infection
- +7 more
-
Copenhagen, Denmark
- +1 more
Dec 25, 2022
T-cell Lymphoma, Virus, Intravenous Injection Trial (Oncolytic Virus Injection(RT-01))
Not yet recruiting
- T-cell Lymphoma
- +2 more
- Oncolytic Virus Injection(RT-01)
- (no location specified)
May 18, 2022
Advanced Solid Tumor Trial in Xuzhou (Oncolytic Virus Injection(Revottack)+PD-1)
Not yet recruiting
- Advanced Solid Tumor
- Oncolytic Virus Injection(Revottack)+PD-1
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Dec 1, 2022
Herpes Virus Infections in Kidney Transplant Patients
Recruiting
- Kidney Transplant; Complications
- +2 more
-
Aarhus, Denmark
- +4 more
Jan 30, 2023